A recent article recapping the annual meeting of the America Society of Hospital Pharmacists (ASHP) focuses on how many major hospital systems are establishing pharmacogenomic (PGx) programs to bring personalized medicine to their patients.

Cleveland Clinic launched its Personalized Medication Program within the last year, and other personalized medicine programs profiled in the article include those at St. Jude and Kaiser Permanente.

A lab director at St. Jude summarized that hospital’s success with personalized medicine when she said “We are not only seeing a decrease in side effects but are also getting to the right dosing much quicker,” Dr. Crews told Pharmacy Practice News. “I think using pharmacogenomics testing will become the standard of care across multiple types of practice settings and will be essential to achieve the best outcomes in personalized care.”

The article also provides a figure from NIH that highlights the rapid decrease in sequencing cost as compared to Moore’s Law, a key driver in PGx adoption.